Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Takefumi Komiya"'
Publikováno v:
Thoracic Cancer, Vol 12, Iss 21, Pp 2943-2948 (2021)
Abstract Immune checkpoint inhibitors (ICIs) have become standard pharmacological therapies in patients with non‐small‐cell lung cancer (NSCLC). Because elderly patients with NSCLC are often excluded from clinical trials as a result of lower func
Externí odkaz:
https://doaj.org/article/d29c2360c2114054b9e5913b273d8dc2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesSmall cell lung cancer (SCLC) is a lethal histologic subtype of lung cancer. Although the Commission on Cancer recommends pathological examination of at least 10 lymph nodes dissected (LNDs) for resected early-stage non-small cell lung canc
Externí odkaz:
https://doaj.org/article/bb821ddd3f0e43e0b908a08a74803c81
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 923-932 (2021)
Abstract Immunocheckpoint inhibitors (ICIs) have become a standard pharmacological therapy in non‐small cell lung cancer (NSCLC). Because brain metastases (BMs) have historically been listed as exclusion criteria in previous clinical trials involvi
Externí odkaz:
https://doaj.org/article/b6848d8386b0486389d084f7fd68d45d
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100111- (2021)
Introduction: T components of the current eighth edition of lung cancer American Joint Commission on Cancer (AJCC) staging assignment include size of primary tumor and others such as chest wall invasion. The role of the presence of multiple T3 descri
Externí odkaz:
https://doaj.org/article/9c38e9ed17c149bdb5895960b055bf18
Autor:
Takefumi Komiya, Chao H. Huang
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Recent application of immunotherapy in clinical oncology revolutionized our management of advanced human cancers. Check point inhibitors targeting CTLA4 and PD-1/PD-L1 axis are immunotherapeutic agents currently available to treat a variety of cancer
Externí odkaz:
https://doaj.org/article/07997fea336746e0b1ce7a0bb62856e9
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17430 (2011)
Divergent natural selection rooted in differential resource use can generate and maintain intraspecific eco-morphological divergence (i.e., resource polymorphism), ultimately leading to population splitting and speciation. Differing bottom environmen
Externí odkaz:
https://doaj.org/article/423d67676e124046b35fc329b1c14450
Autor:
Shamsher Khan, Takefumi Komiya
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 24:331-336
Publikováno v:
General Thoracic and Cardiovascular Surgery. 71:189-197
A randomized trial of lobectomy versus segmentectomy for small-sized (≤ 20 mm) non-small cell lung cancer (NSCLC) showed that patients who had undergone segmentectomy had a significantly longer overall survival (OS) than those who had lobectomy. Mo
Publikováno v:
World Journal of Oncology. 13:1-7
Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their low incidence, it is challenging to conduct clinical trials and develop treatment guidelines. Although surgery is the most common approach for a resectable tumor, va
Autor:
Srikiran, Dasari, Takefumi, Komiya
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:217-220
Although concurrent chemoradiation has been the standard of care for unresectable stage III non-small cell lung cancer (NSCLC) due to increased survival and decreased disease progression, patients with poor performance status cannot tolerate chemothe